Recently, the targeting of PERK inhibition in a mouse model of PD indicated that the PERK inhibitor GSK2606414 protected DA neurons in the SNpc against cell death induced by the PD neurotoxin 6-hydroxydopamine (6-OHDA), thereby improving the motor performance of PD mice (211). The gene discussed is EIF2AK3; the disease is Parkinson disease.